The Effect of treatment with Duodopa on the composition of

PI: Yair Zlotnik. Funded: Grant

Microbiome in patient with Parkinson's Disease

PI: Amir Horev. Funded: Biogen

CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL

PI: Anat Horev. Funded: Mayo Clinic

The Impact of Migraine on Quality of Life in Israel's Negev Population.

PI: Gal Ifergane. Funded: Teva

An observational study to investigate the feasibility and patient/caregiver/investigator satisfaction of video-assisted telenursing use in nurse support programs with LCIG (FACILITATE-CARE)

PI: Yair Zlotnik. Funded: AbbVie

A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA [ANDEXANET ALFA FOR INJECTION] IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR

PI: Anat Horev. Funded: Portola Pharmaceuticals

A, Multi-center, Open Label, Single -Arm Clinical Study to Assess the Safety and Efficacy of the Vibrant Capsule in PD patients, for the Treatment of Chronic Idiopathic Constipatione

PI: Yair Zlotnik. Funded: with Galilee Medical Center

Evaluation of Neurosteer System (Quantitative EEG Features)

PI: Gal Ifergane. Funded: Neurosteer LTD

Safety and efficacy of Maraviroc in post-stroke cognitive impairment

PI: Anat Horev. Funded: Collaboration with Ichilov

A RANDOMIZED, DOUBLE BLIND, MULTICENTER, MULTINATIONAL, PLACEBO CONTROLLED, PARALLEL GROUP, SINGLE DOSE, ADAPTIVE EFFICACY AND SAFETY STUDY OF GLENZOCIMAB USED AS AN ADD-ON THERAPY ON TOP OF STANDARD OF CARE IN THE 4.5 HOURS FOLLOWING AN ACUTE ISCHEMIC STROKE – THE ACTISAVE STUDY

PI: Anat Horev

Stroke

PI: Anat Horev

A Multicenter, Operationally Seamless, Double-Blind, Dose-Ranging Placebo-Controlled, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and

PI: Anat Horev